Nonrulemaking

Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry; Availability

Documents
1
Total comments
42
all analyzed
Comment status
Open
Last activity
Jun 21, 2026
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.